RankAlpha logo
Back to Rankings

EXEL

ExelixisA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
EXEL vs peer average
80/100
EXEL vs. peer average (A vs. C)
Grade spread
A 1 · B 1 · C 7 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Diversified biotech peer with significant oncology exposure and stronger scale; highlights how EXEL still trades more on a concentrated cabozantinib base plus zanzalintinib pipeline execution.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
EXEL
Exelixis
AMGN
Amgen
Grade
A
C
Momentum
77
36
Value
65
64
Sentiment
49
47
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs AMGN

EXEL / AMGN
Grade Position
Above peers
EXEL vs. peer average (A vs. C)
80/100
Momentum
77
EXEL
Value
65
EXEL
Sentiment
49
EXEL

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EXEL
1
AMGN
AMGN
C
60/100
+2
2
GILD
GILD
C
60/100
+2
3
IONS
IONS
C
60/100
+2
4
BBIO
BridgeBio Pharma Inc Common
C
60/100
+2
5
ELAN
Elanco Animal Health Inc Common
C
60/100
+2
AMGN is the first peer returned for this comparison set.